Yulun Wang, Head of Research & Development at Teladoc Health, Inc. (TDOC), sold 8,000 shares at $260.00 ($2.1M) on 2021-01-22, disclosed to the SEC on 2021-01-25.
Open-market sale of $2.1M TDOC by Head of Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TDOC | SELL | 2021-01-19 | $1.8M | — | Filing → |
| TDOC | SELL | 2020-12-16 | $498K | — | Filing → |
| TDOC | SELL | 2020-12-07 | $1.2M | — | Filing → |